This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Public Health Agency of Turkey, Department of Cancer, Cancer Registry in Turkey. Available from: http://kanser.gov.tr/daire-faaliyetleri/kanser-kayitciligi/108-tьrkiyede-kanser-kayitcigi.htmlAvailable fromhttp://kanser.gov.tr/daire-faaliyetleri/kanser-kayitciligi/108-tьrkiyede-kanser-kayitcigi.htmlSearch in Google Scholar
McPherson K, Steel CM, Dixon JM. ABC of breast diseases. Breast cancer-epidemiology, risk factors, and genetics. BMJ. 2000; 321(7261): 624-628.McPhersonKSteelCMDixonJMABC of breast diseases20003217261624–62810.1136/bmj.321.7261.624Search in Google Scholar
Petrucelli N, Daly MB, Pal T. BRCA1- and BRCA2-Associated Hereditary Breast and Ovarian Cancer, 1998 [updated 2016]. In: Adam MP, Ardinger HH, Pagan RA, Wallace SE, Amemiya A, Bean LJH, et al., Eds. GeneReviews® [Internet]. Seattle (WA, USA): University of Washington, Seattle, WA, USA. (https://www.ncbi.nlm.nih.gov/pubmed/20301425.)PetrucelliNDalyMBPalTBRCA1- and BRCA2-Associated Hereditary Breast and Ovarian Cancer, 1998 [updated 2016]Adam MP, Ardinger HH, Pagan RA, Wallace SE, Amemiya A, Bean LJH, et al., EdsSeattle (WA, USA)University of Washington, Seattle, WA, USA(https://www.ncbi.nlm.nih.gov/pubmed/20301425.)Search in Google Scholar
Ford D, Easton DF, Stratton M, Narod S, Goldgar D, Devilee P, et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet. 1998; 62(3): 676-689.FordDEastonDFStrattonMNarodSGoldgarDDevileePGenetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families1998623676–68910.1086/301749Search in Google Scholar
Easton DF, Ford D, Bishop DT. Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Am J Hum Genet. 1995; 56(1): 265-271.EastonDFFordDBishopDTBreast and ovarian cancer incidence in BRCA1-mutation carriers1995561265–271Search in Google Scholar
Antoniou A, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: A combined analysis of 22 studies. Am J Hum Genet. 2003; 72(5): 1117-1130.AntoniouAPharoahPDNarodSRischHAEyfjordJEHopperJLAverage risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: A combined analysis of 22 studies20037251117–113010.1086/375033Search in Google Scholar
Smith A, Moran A, Boyd MC, Bulman M, Shenton A, Smith L, et al. Phenocopies in BRCA1 and BRCA2 families: Evidence for modifier genes and implications for screening. J Med Genet. 2007; 44(1): 10-15.SmithAMoranABoydMCBulmanMShentonASmithLPhenocopies in BRCA1 and BRCA2 families: Evidence for modifier genes and implications for screening200744110–1510.1136/jmg.2006.043091Search in Google Scholar
Laubli H, Borsig L. Selectins promote tumor metastasis. Semin Cancer Biol. 2010; 20(3): 169-177.LaubliHBorsigLSelectins promote tumor metastasis2010203169–17710.1016/j.semcancer.2010.04.005Search in Google Scholar
Ley K. The role of selectins in inflammation and disease. Trends Mol Med. 2003; 9(6): 263-268.LeyKThe role of selectins in inflammation and disease200396263–26810.1016/S1471-4914(03)00071-6Search in Google Scholar
Krause T, Turner GA. Are selectins involved in metastasis? Clin Exp Metastasis. 1999; 17(3): 183-192.KrauseTTurnerGAAre selectins involved in metastasis?1999173183–19210.1023/A:1006626500852Search in Google Scholar
Khatib AM, Fallavollita L, Wancewicz EV, Monia BP, Brodt P. Inhibition of hepatic endothelial E-selectin expression by C-raf antisense oligonucleotides blocks colorectal carcinoma liver metastasis. Cancer Res. 2002; 62(19): 5393-5398.KhatibAMFallavollitaLWancewiczEVMoniaBPBrodtPInhibition of hepatic endothelial E-selectin expression by C-raf antisense oligonucleotides blocks colorectal carcinoma liver metastasis200262195393–5398Search in Google Scholar
Laferriere J, Houle F, Taher MM, Valerie K, Huot J. Transendothelial migration of colon carcinoma cells requires expression of E-selectin by endothelial cells and activation of stress-activated protein kinase-2 (SAPK2/p38) in the tumor cells. J Biol Chem. 2001; 276(36): 33762-33772.LaferriereJHouleFTaherMMValerieKHuotJTransendothelial migration of colon carcinoma cells requires expression of E-selectin by endothelial cells and activation of stress-activated protein kinase-2 (SAPK2/p38) in the tumor cells20012763633762–3377210.1074/jbc.M00856420011448946Search in Google Scholar
Bal N, Kocer NE, Ertorer ME, Canpolat ET, Kayaselcuk F. Maspin, E-selectin, and P-selectin expressions in papillary thyroid carcinomas and their correlation with prognostic parameters. Pathol Res Pract. 2008; 204(10): 743-750.BalNKocerNEErtorerMECanpolatETKayaselcukFMaspin, E-selectin, and P-selectin expressions in papillary thyroid carcinomas and their correlation with prognostic parameters200820410743–75010.1016/j.prp.2008.04.01618597952Search in Google Scholar
Banks RE, Gearing AJ, Hemingway IK, Norfolk DR, Perren TJ, Selby PJ. Circulating intercellular adhesion molecule-1 (ICAM-1), E-selectin and vascular cell adhesion molecule-1 (VCAM-1) in human malignancies. Br J Cancer. 1993; 68(1): 122-124.BanksREGearingAJHemingwayIKNorfolkDRPerrenTJSelbyPJCirculating intercellular adhesion molecule-1 (ICAM-1), E-selectin and vascular cell adhesion molecule-1 (VCAM-1) in human malignancies1993681122–12410.1038/bjc.1993.29819683217686390Search in Google Scholar
Dymicka-Piekarska V, Kemona H. Does colorectal cancer clinical advancement affect adhesion molecules (sP-selectin, sE-selectin and ICAM-1) concentration? Thromb Res. 2009; 124(1): 80-83.Dymicka-PiekarskaVKemonaHDoes colorectal cancer clinical advancement affect adhesion molecules (sP-selectin, sE-selectin and ICAM-1) concentration?2009124180–8310.1016/j.thromres.2008.11.021Search in Google Scholar
Ke JJ, Shao QS, Ling ZQ. Expression of E-selectin, integrin β1 and immunoglobulin superfamily member in human gastric carcinoma cells and its clinicopathologic significance. World J Gastroenterol. 2006; 12(22): 3609-3611.KeJJShaoQSLingZQExpression of E-selectin, integrin β1 and immunoglobulin superfamily member in human gastric carcinoma cells and its clinicopathologic significance200612223609–361110.3748/wjg.v12.i22.3609Search in Google Scholar
Revelle BM, Scott D, Beck PJ. Single amino acid residues in the E- and P-selectin epidermal growth factor domains can determine carbohydrate binding specificity. J Biol Chem. 1996; 271(11): 16160-16170.RevelleBMScottDBeckPJSingle amino acid residues in the E- and P-selectin epidermal growth factor domains can determine carbohydrate binding specificity19962711116160–1617010.1074/jbc.271.27.16160Search in Google Scholar
Alexiou D, Karayiannakis AJ, Syrigos KN, Zbar A, Sekara E, Michail P, et al. Clinical significance of serum levels of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in gastric cancer patients. Am J Gastroenterol. 2003; 98(2): 478-485.AlexiouDKarayiannakisAJSyrigosKNZbarASekaraEMichailPClinical significance of serum levels of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in gastric cancer patients2003982478–48510.1111/j.1572-0241.2003.07259.xSearch in Google Scholar
Reference SNP (refSNP) Cluster Report: rs5361. Available from: http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=5361http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=5361Search in Google Scholar
Rao RM, Clarke JL, Ortlepp S, Robinson MK, Landis RC, Haskard DO. The S128R polymorphism of E-selectin mediates neuraminidase-resistant tethering of myeloid cells under shear flow. Eur J Immunol. 2002; 32(1): 251-260.RaoRMClarkeJLOrtleppSRobinsonMKLandisRCHaskardDOThe S128R polymorphism of E-selectin mediates neuraminidase-resistant tethering of myeloid cells under shear flow2002321251–26010.1002/1521-4141(200201)32:1<251::AID-IMMU251>3.0.CO;2-0Search in Google Scholar
Rao RM, Haskard DO, Landis RC. Enhanced recruitment of Th2 and CLA-negative lymphocytes by the S128R polymorphism of E-selectin. J Immunol. 2002; 169(10): 5860-5865.RaoRMHaskardDOLandisRCEnhanced recruitment of Th2 and CLA-negative lymphocytes by the S128R polymorphism of E-selectin2002169105860–586510.4049/jimmunol.169.10.5860Search in Google Scholar
Wenzel K, Hanke R, Speer A. Polymorphism in the human E-selectin gene detected by PCR-SSCP. Hum Genet. 1994; 94(4): 452-453.WenzelKHankeRSpeerAPolymorphism in the human E-selectin gene detected by PCR-SSCP1994944452–45310.1007/BF00201614Search in Google Scholar
Cheng DY, Hao YW, Zhou WL, Ma YR. E-selectin S128R polymorphism is associated with cancer risk: A meta-analysis. Asian Pac J Cancer Prev. 2014; 15(7): 3247-3252.ChengDYHaoYWZhouWLMaYRE-selectin S128R polymorphism is associated with cancer risk: A meta-analysis20141573247–325210.7314/APJCP.2014.15.7.3247Search in Google Scholar
NCCN Guideline. Genetic/Familial High-Risk Assessment: Breast and Ovarian Version 1, 2018. Professional version available from (subscription needed): https://www.nccn.org/professionals/physician_gls/pdf/genetics_screening.pdfNCCN Guidelinehttps://www.nccn.org/professionals/physician_gls/pdf/genetics_screening.pdfSearch in Google Scholar
Xia HZ, Du WD, Wu Q, Chen G, Zhou Y, Tang XF, et al. E-selectin rs5361 and FCGR2A rs1801274 variants were associated with increased risk of gastric cancer in a Chinese population. Mol Carcinog. 2012; 51(8): 597-607.XiaHZDuWDWuQChenGZhouYTangXFE-selectin rs5361 and FCGR2A rs1801274 variants were associated with increased risk of gastric cancer in a Chinese population2012518597–60710.1002/mc.20828Search in Google Scholar
Liarmakopoulos E, Gazouli M, Aravantinos G, Theodoropoulos G, Rizos S, Vaiopoulou A, et al. E-Selectin S128R gene polymorphism in gastric cancer. Int J Biol Markers. 2013; 28(1): 38-42.LiarmakopoulosEGazouliMAravantinosGTheodoropoulosGRizosSVaiopoulouAE-Selectin S128R gene polymorphism in gastric cancer201328138–4210.5301/JBM.2012.9582Search in Google Scholar
Hebbar M, Adenis A, Revillion F, Duhamel A, Romano O, Truant S, et al. E-selectin gene S128R polymorphism is associated with poor prognosis in patients with stage II or III colorectal cancer. Eur J Cancer. 2009; 45(10): 1871-1876.HebbarMAdenisARevillionFDuhamelARomanoOTruantSE-selectin gene S128R polymorphism is associated with poor prognosis in patients with stage II or III colorectal cancer200945101871–187610.1016/j.ejca.2009.03.01119361981Search in Google Scholar
Panoussopoulos GS, Theodoropoulos G, Michalopoulos NV, Gazouli M, Flessas J, Taka S, et al. Analysis of E-Selectin S128R gene polymorphism in pancreatic cancer. J Surg Oncol. 2010; 102(6): 604-607.PanoussopoulosGSTheodoropoulosGMichalopoulosNVGazouliMFlessasJTakaSAnalysis of E-Selectin S128R gene polymorphism in pancreatic cancer20101026604–60710.1002/jso.2164820607758Search in Google Scholar
Kontogianni P, Zambirinis CP, Theodoropoulos G, Gazouli M, Michalopoulos NV, Flessas J, et al. The impact of the stromal cell-derived factor-1-3’A and E-selectin S128R polymorphisms on breast cancer. Mol Biol Rep. 2013; 40(1): 43-50.KontogianniPZambirinisCPTheodoropoulosGGazouliMMichalopoulosNVFlessasJThe impact of the stromal cell-derived factor-1-3’A and E-selectin S128R polymorphisms on breast cancer201340143–5010.1007/s11033-012-1989-x23129313Search in Google Scholar
Naidu R, Har YC, Taib NA. Polymorphic variant Ser128Arg of E-Selectin is associated with breast cancer risk and high grade tumors. Onkologie. 2011; 34(11): 592-597.NaiduRHarYCTaibNAPolymorphic variant Ser128Arg of E-Selectin is associated with breast cancer risk and high grade tumors20113411592–59710.1159/00033406022104155Search in Google Scholar